Your browser doesn't support javascript.
Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study.
Machida, Masaki; Kikuchi, Hiroyuki; Kojima, Takako; Nakamura, Itaru; Saito, Reiko; Nakaya, Tomoki; Hanibuchi, Tomoya; Takamiya, Tomoko; Odagiri, Yuko; Fukushima, Noritoshi; Amagasa, Shiho; Watanabe, Hidehiro; Inoue, Shigeru.
  • Machida M; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo, Japan.
  • Kikuchi H; Department of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.
  • Kojima T; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo, Japan.
  • Nakamura I; Department of International Medical Communications, Tokyo Medical University, Tokyo, Japan.
  • Saito R; Department of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.
  • Nakaya T; Division of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Hanibuchi T; Graduate School of Environmental Studies, Tohoku University, Sendai, Japan.
  • Takamiya T; Graduate School of Environmental Studies, Tohoku University, Sendai, Japan.
  • Odagiri Y; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo, Japan.
  • Fukushima N; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo, Japan.
  • Amagasa S; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo, Japan.
  • Watanabe H; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo, Japan.
  • Inoue S; Department of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.
Hum Vaccin Immunother ; 18(5): 2086773, 2022 11 30.
Article in English | MEDLINE | ID: covidwho-1895724
ABSTRACT
To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR 1.73, 95%CI 1.18-2.54; OR 1.58, 95%CI 1.22-2.05; OR 3.05, 95%CI 2.15-4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Social Capital / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2022.2086773

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Social Capital / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2022.2086773